BD3095145
1-(2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione , 95% , 830346-47-9
Pack Size | Price | Stock | Quantity |
100mg | RMB32.00 | In Stock |
|
250mg | RMB47.20 | In Stock |
|
1g | RMB128.80 | In Stock |
|
5g | RMB414.40 | In Stock |
|
25g | RMB1377.60 | In Stock |
|
100g | RMB3854.40 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Density | 1.413±0.06 g/cm3(Predicted) |
storage temp. | Sealed in dry,Room Temperature |
pka | 9.49±0.40(Predicted) |
InChI | InChI=1S/C13H10F4N2O2/c1-7-5-11(20)18-12(21)19(7)6-8-9(13(15,16)17)3-2-4-10(8)14/h2-5H,6H2,1H3,(H,18,20,21) |
InChIKey | IJRKKZXPXBTHER-UHFFFAOYSA-N |
SMILES | C1(=O)N(CC2=C(C(F)(F)F)C=CC=C2F)C(C)=CC(=O)N1 |
Description and Uses
1-(2-Fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione is a pharmaceutical intermediate ingredient used in the preparation of Elagolix sodium, which is FDA-approved for the treatment of pain associated with moderate to severe pain associated with endometriosis.
Safety
Symbol(GHS) | ![]() GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |